Phillip Frost, OPKO Health, Inc. (OPK)’s insider Bought 30,000 Shares; Hightower Advisors Increased Nike (NKE) Stake By $25.09 Million

April 16, 2018 - By Darrin Black

NIKE, Inc. (NYSE:NKE) Logo

Hightower Advisors Llc increased Nike Inc (NKE) stake by 20232.55% reported in 2017Q4 SEC filing. Hightower Advisors Llc acquired 404,651 shares as Nike Inc (NKE)’s stock rose 4.55%. The Hightower Advisors Llc holds 406,651 shares with $25.55M value, up from 2,000 last quarter. Nike Inc now has $108.39 billion valuation. The stock decreased 0.77% or $0.52 during the last trading session, reaching $67.25. About 4.30M shares traded. NIKE, Inc. (NYSE:NKE) has risen 18.31% since April 16, 2017 and is uptrending. It has outperformed by 6.76% the S&P500.

Since December 11, 2017, it had 0 buys, and 8 insider sales for $45.81 million activity. SPRUNK ERIC D also sold $6.77 million worth of NIKE, Inc. (NYSE:NKE) shares. Matheson Monique S. had sold 10,000 shares worth $620,000 on Monday, December 11. Another trade for 135,000 shares valued at $9.45 million was made by PARKER MARK G on Tuesday, February 27. Slusher John F had sold 74,278 shares worth $4.75 million. Another trade for 100,000 shares valued at $6.85 million was sold by EDWARDS TREVOR A.

Hightower Advisors Llc decreased Ishares Gold Trust (IAU) stake by 101,171 shares to 89,774 valued at $1.13 million in 2017Q4. It also reduced Nuance Communications Inc (NASDAQ:NUAN) stake by 102,108 shares and now owns 96,657 shares. Ishares Tr (IWP) was reduced too.

Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.06, from 0.8 in 2017Q3. It worsened, as 70 investors sold NKE shares while 501 reduced holdings. 109 funds opened positions while 312 raised stakes. 1.01 billion shares or 2.95% more from 985.62 million shares in 2017Q3 were reported. King Luther Capital Mngmt reported 598,645 shares or 0.31% of all its holdings. Duff & Phelps Invest Mngmt reported 14,480 shares. 10.61M are owned by Price T Rowe Assocs Inc Md. Clearbridge Invs Limited Liability invested in 160,419 shares. Franklin Street Advisors Nc accumulated 138,679 shares. Teacher Retirement System Of Texas has invested 0.15% of its portfolio in NIKE, Inc. (NYSE:NKE). Pinnacle Hldgs Ltd Co owns 16,481 shares. Moreover, Tobam has 0.02% invested in NIKE, Inc. (NYSE:NKE) for 6,942 shares. Girard Ptnrs Ltd has invested 0.33% of its portfolio in NIKE, Inc. (NYSE:NKE). Sol Capital invested 0.2% in NIKE, Inc. (NYSE:NKE). Ifc Fl reported 0.02% of its portfolio in NIKE, Inc. (NYSE:NKE). Kempen Nv has 64,300 shares for 0.32% of their portfolio. Zwj Counsel has invested 0.04% in NIKE, Inc. (NYSE:NKE). Moreover, First Personal Financial has 0.06% invested in NIKE, Inc. (NYSE:NKE) for 5,282 shares. Ahl Llp holds 80,633 shares.

Among 44 analysts covering Nike Inc. (NYSE:NKE), 25 have Buy rating, 2 Sell and 17 Hold. Therefore 57% are positive. Nike Inc. had 232 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was maintained by Wells Fargo on Wednesday, September 28 with “Market Perform”. The firm has “Mkt Perform” rating given on Friday, September 25 by FBR Capital. The company was maintained on Thursday, December 17 by Jefferies. The stock has “Buy” rating by B. Riley & Co on Friday, October 16. As per Wednesday, June 29, the company rating was maintained by Goldman Sachs. The firm has “Buy” rating by Susquehanna given on Thursday, June 15. The rating was maintained by Canaccord Genuity on Sunday, January 7 with “Hold”. The company was initiated on Wednesday, November 2 by Wedbush. Piper Jaffray maintained NIKE, Inc. (NYSE:NKE) rating on Thursday, March 23. Piper Jaffray has “Neutral” rating and $51 target. Morgan Stanley downgraded NIKE, Inc. (NYSE:NKE) rating on Wednesday, June 1. Morgan Stanley has “Equal-Weight” rating and $60 target.

The stock decreased 0.66% or $0.02 during the last trading session, reaching $2.99. About 2.03M shares traded. OPKO Health, Inc. (NASDAQ:OPK) has declined 60.81% since April 16, 2017 and is downtrending. It has underperformed by 72.36% the S&P500.

Since January 22, 2018, it had 35 insider buys, and 0 insider sales for $9.09 million activity. 30,000 OPKO Health, Inc. (NASDAQ:OPK) shares with value of $101,384 were bought by FROST PHILLIP MD ET AL. 10,000 shares were bought by Fishel Robert Scott, worth $31,600. Shares for $7,011 were bought by Logal Adam. The insider Rubin Steven D bought 6,000 shares worth $19,500.

Investors sentiment decreased to 0.84 in Q4 2017. Its down 0.30, from 1.14 in 2017Q3. It dived, as 32 investors sold OPKO Health, Inc. shares while 60 reduced holdings. 24 funds opened positions while 53 raised stakes. 119.15 million shares or 0.51% less from 119.76 million shares in 2017Q3 were reported. Counselors Inc holds 0% of its portfolio in OPKO Health, Inc. (NASDAQ:OPK) for 19,465 shares. Asset Management invested 0% in OPKO Health, Inc. (NASDAQ:OPK). Price T Rowe Associates Md, Maryland-based fund reported 58,193 shares. Lpl Fincl Ltd Liability holds 13,374 shares or 0% of its portfolio. Comerica Natl Bank owns 0% invested in OPKO Health, Inc. (NASDAQ:OPK) for 13,042 shares. Teacher Retirement System Of Texas has invested 0% in OPKO Health, Inc. (NASDAQ:OPK). Old West Mngmt Ltd Com owns 0.13% invested in OPKO Health, Inc. (NASDAQ:OPK) for 45,770 shares. Two Sigma Ltd Liability Co invested in 18,352 shares or 0% of the stock. Blb&B Advsr Limited Com accumulated 10,820 shares or 0.01% of the stock. Moreover, Clal Insur Hldgs Limited has 0.09% invested in OPKO Health, Inc. (NASDAQ:OPK). Proshare Advsr Ltd Liability Company invested in 0.01% or 311,186 shares. Schwab Charles Invest Management, California-based fund reported 1.56M shares. Wells Fargo And Mn holds 487,963 shares. Invesco Ltd reported 1.51M shares. Hsbc Pcl holds 0% or 27,286 shares in its portfolio.

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, and Mexico. The company has market cap of $1.67 billion. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. It currently has negative earnings. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform.

NIKE, Inc. (NYSE:NKE) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>